Wilms' tumor 1-associating protein (WTAP) has been reported to be a ubiquitously expressed nuclear protein. Although a relation to splicing factors has been postulated, its actual physiological function still remains to be elucidated. To investigate the role of WTAP, we generated WTAP-knockout mice and performed small interfering RNA (siRNA)-mediated knockdown analyses in primary cultured cells. In DNA microarrays using human umbilical vein endothelial cells, WTAP-targeted siRNA treatment resulted in markedly reduced expression of cell-cycle-related genes. siRNA-mediated WTAP knockdown down-regulated the stability of cyclin A2 mRNA through a nine-nucleotide essential sequence in cyclin A2 mRNA 3 UTR. WTAP knockdown induced G 2 accumulation, which is partially rescued by adenoviral overexpression of cyclin A2. Moreover, WTAP-null mice exhibited proliferative failure with death resulting at approximately embryonic day 6.5, an etiology almost identical to cyclin A2-null mice. Collectively, these findings establish WTAP as an essential factor for the stabilization of cyclin A2 mRNA, thereby regulating G 2͞M cell-cycle transition.
W
ilms' tumor 1-associating protein (WTAP) was identified as a protein that specifically interacts with Wilms' tumor 1 (WT1) in both in vitro and in vivo assays (1) . The Wilms tumor suppressor gene WT1 is essential for the normal development of the bipotential gonad, and the primordial kidney (2) (3) (4) and is associated with a common form of pediatric kidney cancer (5) . WTAP and WT1 are present together throughout the nucleoplasm as well as in nuclear speckles and partially colocalize with splicing factors (1) . WTAP was also identified as the mammalian homologue of the Drosophila female-lethal-2-D [fl(2)D]. fl(2)D is required for the female developmental pathway because of its activation of female-specific patterns of alternative splicing on SXL and transformer (tra) premRNA (6, 7) . The presence of the lethal phenotype of the fl(2)D mutation in both sexes suggests an additional function for the gene (8) . In vitro splicing assays demonstrated that depletion of WTAP from HeLa nuclear extracts affects tra but not AdML (a model adenovirus RNA) splicing, suggesting a biochemical function in female-specific splicing regulation (9) . Furthermore, proteomic studies isolated WTAP as one of 145 spliceosomal proteins assembled on two distinct premRNAs, adenovirus major late and Fushi tarazu (10) . While investigating GATA function in vascular endothelial cells, we serendipitously identified WTAP, in addition to GATAassociating proteins and hematopoietically expressed homeobox, from a yeast two-hybrid screen (11) . In spite of these refined studies, the exact function of WTAP remains unknown.
In the present study, we investigated the function of WTAP in vitro by using RNAi in primary cultured cells and in vivo by generating WTAP-knockout mice. Here, we demonstrate that WTAP is a factor essential for cyclin A2 mRNA stabilization and G 2 ͞M transition, the understanding of which should yield significant insight into posttranscriptional regulation, as well as cellcycle regulation in normal and͞or tumor cells.
Results

WTAP-Knockdown Cells Display Markedly Reduced Expression of
Cyclin A2 and B and Cell Division-Related Genes. To investigate the physiological function of WTAP, we examined the relative influence of WTAP on gene expression in human umbilical vein endothelial cells (HUVEC) by using an RNAi-based approach.
To examine WTAP expression, we first generated an anti-WTAP antibody raised in rabbits by using bacterially expressed GST-WTAP protein.
Its specificity for WTAP was tested by Western blot analysis (Fig. 1A) . A Ϸ50-kDa band corresponding to myc-tagged WTAP was detectable by both anti-myc and -WTAP antibodies ( Fig. 1 A, arrow) . Additionally, low levels of endogenous WTAP were also detectable by anti-WTAP antibody. In HUVEC cells, after WTAP siRNA transfection, WTAP protein levels were reduced to Ͻ20% of that in control siRNA-transfected cells (Fig. 1B) . Subsequently, RNAs from WTAP or control siRNA-treated cells were subjected to microarray analysis. Of 38,500 genes present on a U133 Plus 2.0 array, 329 genes were Ն2-fold down-regulated and 324 genes Ն2-fold up-regulated by WTAP knockdown confirmed in two independent experiments (Tables 3 and 4 , which are published as supporting information on the PNAS web site). The top 30 down-or up-regulated genes are listed in Tables 5 and 6 , which are published as supporting information on the PNAS web site, in which genes with unknown functions have been excluded. Interestingly, the major genes exhibiting decreased expression are all related to the cell division cycle, including cyclins A2, B1, B2, and CDC20, whereas the up-regulated genes are related to metabolism, inflammation, or cell adhesion.
siRNA-Mediated WTAP Reduction Results in G2-Phase Accumulation.
To examine the effect of WTAP reduction on cell cycle, proliferation assays and FACS analysis were performed. As shown in Fig. 1C , HUVEC in the control group exhibited moderate growth for the first 48 h after siRNA transfection, then increased 3.5-fold in cell number by 72 h. In contrast, WTAP siRNAAuthor contributions: K.H., M.U., and T.M. contributed equally to this work; K.H., M.U., T.M., H.O., S.T., M.Y., H.A., P.C.R., D.E.H., T.H., and T.K. designed research; K.H. and M.U. performed research; K.H. analyzed data; and K.H., T.M., P.C.R., and T.H. wrote the paper. treated cells underwent growth inhibition, as evidenced by the lack of an increase in cell number over time. Moreover, FACS analysis revealed that WTAP siRNA-treated cells exhibited a significantly higher proportion in G 2 (21%) compared with that of control cells (8%; Fig. 1D ). These data demonstrate that WTAP reduction leads to growth arrest in G 2 or reduction in progression through G 2 . To determine whether this effect is specific to HUVEC, we next performed the same experiments in primary human fibroblasts. G 2 accumulation was also induced in human neonatal dermal fibroblasts (Fig. 7 , which is published as supporting information on the PNAS web site). This finding demonstrates that the growth inhibition caused by WTAP reduction is not specific to endothelial cells but can be induced in other cell types as well. The effect of WTAP knockdown on cyclin A2 promoter activity was studied by using a cyclin A2 promoter-luciferase reporter assay. The full promoter region of cyclin A2, corresponding to Ϫ737 to ϩ108 bp (start site, ϩ1), was inserted into the pGL3-basic plasmid. (D) Actinomycin D (AMD) was added at 24 h after siRNA transfection, and total RNA was prepared at each indicated time point. The remaining cyclin A2 mRNA was measured by quantitative real-time PCR and normalized to rpL32 mRNA, which has a half-life of Ͼ25 h. (E) Influence of the 3ЈUTR of cyclin A2 mRNA on WTAP-mediated mRNA stability. A luciferase-cyclin A2 3ЈUTR chimeric plasmid was constructed by subcloning in the 3ЈUTR fragment of cyclin A2 immediately downstream of the firefly luciferase ORF in a pGL3-control vector. At 12 h after siRNA transfection, HUVEC were transiently transfected with the chimeric luciferase-cyclin A2 3ЈUTR plasmid. Eighteen hours later, dual-luciferase assays were performed. Relative luciferase activity (firefly͞Renilla) was normalized to the relative basal luciferase activity obtained from a pGL3-control vector. (F) Responsible region for WTAP-mediated mRNA stability was analyzed by using deletion constructs of cyclin A2 mRNA 3ЈUTR. *, P Ͻ 0.05; **, P Ͻ 0.001 vs. control. been reported that cyclin A mutant Drosophila embryos undergo cell-cycle arrest in G 2 (12) , and somatic mammalian cells are blocked at G 2 on ablation of cyclin A (13) . Hence, we hypothesized that the G 2 accumulation brought about by WTAP reduction was because of the loss of cyclin A2 expression and further investigated how WTAP affects cyclin A2 mRNA expression. We first confirmed that WTAP knockdown led to a decrease in cyclin A2 at the mRNA and protein levels. Quantitative real-time PCR analysis revealed that the cyclin A2 mRNA level was decreased to 10% that of controls within 24 h after siRNA transfection and, as a result, reduction in the cyclin A2 protein level was observed by Western blot analysis ( Fig. 2  A and B) . To investigate the mechanism responsible for the decrease in cyclin A2 mRNA levels, we examined the effect of WTAP on cyclin A2 promoter activity and mRNA stability in HUVEC. By using a cyclin A2 promoter-luciferase reporter construct, the effect of WTAP knockdown on cyclin A2 promoter activity was examined. The full promoter region of cyclin A2, corresponding to Ϫ737 to ϩ108 bp (start site, ϩ1), was inserted into a pGL3-basic plasmid. As shown in Fig. 2C , RNAi of WTAP did not result in any substantial change in luciferase activity, suggesting that WTAP has no obvious effect on transcription from the cyclin A2 promoter. Next, we studied the half-life of cyclin A2 mRNA by using standard actinomycin D-based methods to investigate whether its low expression level was because of enhanced degradation of its mRNA. At 24 h after siRNA transfection, 5 g͞ml actinomycin D was added to the medium, and RNA was isolated at each indicated time point. The cyclin A2 mRNA remaining was measured by quantitative real-time PCR normalized against the stable rpL32 mRNA (T 1/2 Ն 25 h). In the absence of WTAP, the cyclin A2 mRNA half-life significantly declined from 2.8 h, in control siRNAtreated cells, to 1.3 h (Fig. 2D) . To further examine cyclin A2 mRNA stability, we performed a reporter assay by using a firefly luciferase-cyclin A2 3ЈUTR chimeric plasmid constructed by conjugating a 3ЈUTR fragment of cyclin A2 into a pGL3-control vector. The reporter plasmids were cotransfected with a CMVRenilla luciferase reporter plasmid into HUVEC 12 h after siRNA transfection. Eighteen hours later, dual-luciferase assays were performed. The relative luciferase activity (firefly͞Renilla) was normalized to the basal relative luciferase activity obtained from the pGL3-control vector alone. A significant decrease in luciferase activity was observed in WTAP siRNA-treated cells (Ϸ40%) compared with that in control cells (Fig. 2E) . These findings suggest that WTAP regulates cyclin A2 mRNA stabilization through its effect on cyclin A2 3ЈUTR. To determine the responsible region for WTAP-mediated stabilization, we generated 3ЈUTR deletion constructs and used reporter assays (Fig. 2F ). There are three AUUUA motifs, sequences known to be involved in mRNA decay, in the 3ЈUTR of cyclin A2 mRNA at ϩ1,686, ϩ2,297, and ϩ2,417. Notably, a 1,387͞1,651 construct (fragment A) with no AUUUA motif gave a similar or greater decrease in relative luciferase activity (Ϸ40%) as the 3ЈUTR full construct in WTAP siRNA-treated cells. Deletion of this region (fragment B) completely abolished the loss in luciferase activity induced by WTAP reduction. As expected, fragment C showed no effect after WTAP RNAi.
To identify the responsible region for stabilization by WTAP within fragment A, we undertook a luciferase assay using the deletion constructs of fragment A (Fig. 2F) . Construct (1,565͞ 1,651; fragment E) eliminated the destabilizing activity of WTAP knockdown, as evidenced by an increase in luciferase activity to control levels (Fig. 2F) . These results suggest that the responsible element confirming cyclin A2 mRNA stability is present between 1,507 and 1,565 bp of the 3ЈUTR. Deletion of 1526-34 (del 1526-34) abolished the destabilizing activity, whereas the adjacent deletion of 1535-40 (del 1535-40) showed similar activity to fragment A. Taken together, these findings suggest that ACAAAUUAU, which corresponds to the 3ЈUTR 1526-34, is an essential element required for the WTAPmediated stabilization of cyclin A2 mRNA, in a manner independent of AUUUA motifs. As shown in Fig. 3A , cells infected with adeno-cyclin A2 showed cyclin A2 expression both in the absence or presence of WTAP siRNA. Adeno-cyclin A2 carries the cDNA encoding the human cyclin A2 coding region. These findings are consistent with WTAP-mediated regulation of cyclin A2 expression through the cyclin A2 mRNA 3ЈUTR. Adenovirus-mediated cyclin A2 expression had no effect on the cell-cycle profile (Fig. 3B) . The G 2 accumulation was partially rescued by the overexpression of cyclin A2, whereas the knockdown of WTAP still led to the G 2 accumulation of adeno-control-infected cells.
WTAP-Null Mice Die and Exhibit Proliferative Failure at Approximately
Embryonic Day 6.5 (E6.5). Finally, we extended our studies in vivo using WTAP-null mice. The WTAP-knockout mice were generated by gene trapping by using a retroviral vector integrated between exons 1 and 2 (Fig. 4A ). Genotyping by PCR using three primer sets, which lie on opposite sides of the insertion site, and a gene-trap vector (Fig. 4B) revealed that no newborn homozygous mice were yielded from heterozygous intercrosses (data not shown). This finding demonstrates that WTAP is required for embryonic development. To determine the timing of lethality during embryogenesis, we therefore performed genotyping and histological analysis of embryos from the heterozygous matings. Table 1 depicts genotyping by using the yolk sac DNA of embryos from E8.5 to E10.5. Homozygous WTAPϪ͞Ϫ embryos are obviously small and without an embryo body ( Fig. 5 A and  B ; heterozygous WTAP ϩ͞Ϫ embryos at E8.5 and homozygous littermate, respectively). Histological analyses of decidua during early stages of development revealed that abnormal embryos were observed at E6.5 (Table 2) . Morphologically abnormal embryos are small like blastocysts and exhibit defects in proliferation and an absence of the shapes characteristic of endoderm and ectoderm (Fig. 5 D, E , and H), whereas normal embryos displayed defined layers of embryonic ectoderm and endoderm ( Fig. 5 C and F) by E6.5. Interestingly, these features are strikingly similar to those seen in the cyclin A2 null mutant. Cyclin A2 null mutants cease development at approximately E6.5 and present a morphology reminiscent of blastocysts (14) .
Immunostaining of serial sections with rabbit polyclonal anti-WTAP antibodies revealed that WTAP was detectable in the nuclei of morphologically normal embryos (Fig. 5G) . In contrast, no specific WTAP staining was observed in morphologically abnormal embryos, confirming that these embryos are homozygous null mutants (Fig. 5I) . In addition to the proliferative failures observed in the WTAPϪ͞Ϫ embryos, some presented a dilated proamniotic canal (Fig. 5E ).
Cell-Cycle-Dependent WTAP Expression Is Synchronous with Cyclin A2.
It has been reported that cyclin A2 mRNA stability varies with the cell cycle, which helps account for its cell-cycle-dependent relative abundance (15) . Thus, we next examined the expression of WTAP throughout the cell division cycle. To this end, HUVEC were subjected to cell-cycle synchronization experiments by serum starvation for 36 h, so that cells exhibited G 1 -enriched distribution (Ϸ90%). Then cells were passaged and released from quiescence by exchanging the medium for complete medium EGM2, and cell-cycle progression was monitored by FACS analysis. Protein was harvested at time points when the majority of the cells were in G 1 (87%), S (76%), or G 2 ͞M (55%). As shown in Fig. 6A , WTAP expression varied with the cell cycle. WTAP was low in G 1 , elevated to 1.7-fold in S and 2.1-fold in G 2 . The cell-cycle-dependent expression of cyclin A2 was detected in only the S-and G 2 -rich phases. The cell-cycle-dependent changes in the expression levels of cyclin A2 and WTAP were similar, even though WTAP expression was maintained at a certain basal expression level throughout the cell cycle.
WTAP Binds to the 3UTR of Cyclin A2 mRNA. To investigate the interaction of WTAP protein with cyclin A2 mRNA, we performed RNA EMSAs by using purified GST-WTAP and in vitro synthesized transcripts. GST-WTAP or GST protein alone was incubated with radiolabeled cyclin A2 3ЈUTR transcripts, and the formation of protein-RNA complexes was examined. As shown in Fig. 6C , GST-WTAP bound to the 3ЈUTR of the cyclin A2 mRNA, whereas control GST protein did not. No protein-RNA complexes were detected when GST-WTAP was incubated with the coding region of the cyclin A2 (data not shown).
Discussion
In the present study, our data suggested that WTAP regulates cyclin A2 mRNA stability, and WTAPϪ͞Ϫ mice suffer embryonic lethality because of the loss of cyclin A2 expression. WTAP knockdown reduced cyclin A2 expression to Ϸ10% of control cells by decreasing the stability of cyclin A2 mRNA, suggesting that a specific change in mRNA stability is an important component in the maintenance of the cell cycle. The G 2 accumulation induced by WTAP RNAi is likely because of cyclin A2 mRNA destabilization, because overexpression of cyclin A2 released WTAP siRNA-treated cells from G 2 accumulation. The other mitosis-related genes down-regulated by WTAP RNAi, as detected by microarray analysis, are believed to be secondary effects because of G 2 accumulation.
The regulation of mRNA stability has been recognized as an important process in the control of gene expression. The bestcharacterized cis element mediating mRNA decay is the AU-rich element (ARE) (16) , which is present in the 3ЈUTRs of many mRNAs, including those of growth factors (17) , oncogenes (18) , cytokines (19, 20) , and cell-cycle regulatory proteins (21, 22) . It has been reported that the RNA-binding protein HuR selectively binds to AREs and enhances cyclin A and cyclin B1 mRNA stability (23) . As shown in Fig. 6C , RNA EMSA analysis revealed a direct interaction of WTAP protein with the 3ЈUTR of cyclin A2 mRNA, suggesting that WTAP enhances cyclin A2 mRNA stability by binding its 3ЈUTR. Yet, it remains to be elucidated that other unidentified proteins may function in concert with WTAP to modulate mRNA stability. Based on chimeric luciferase experiments using 3ЈUTR deletion constructs, we demonstrated that the nine-base sequence ACAAAUUAU was required for the regulation of stability by WTAP. There are no previous reports of this sequence being involved in the regulation of mRNA stability. It remains to be determined whether this nine-base sequence itself or the mRNA secondary structure is responsible for WTAP-mediated stabilization of cyclin A2 mRNA.
Murphy et al. (14) demonstrated that a targeted deletion of the murine cyclin A2 gene is embryonically lethal at approximately E6.5, with a blastocyst like morphology, although homozygousnull embryos develop normally until postimplantation, approximately E5.5. It has also been demonstrated that cyclin A2 is not required for cellular progression during the preimplantation nongrowth period of mouse embryogenesis (24) . The timing of lethality and abnormal phenotype reported in cyclin A2-null mice are strikingly similar to those observed in WTAP-null mice, providing further evidence of their functional relationship.
A previous report demonstrated that WTAP has a ubiquitous expression pattern in mouse tissues, as confirmed by RT-PCR experiments (1). We also confirmed its ubiquitous expression in our gene chip database (Fig. 8 , which is published as supporting information on the PNAS web site). Additionally, WTAP was present in nonmitotic potential tissues where cyclin A2 expression is barely detected. Importantly, in ''normal'' tissues, abundant expression of WTAP was observed. Adenoviral overexpression of WTAP in HUVEC did not affect cell proliferation or the cell-cycle profile in HUVEC (data not shown). Thus, we hypothesize that the role of WTAP may be more to maintain cell-cycle progression through the stabilization of cyclin A2 mRNA than to promote it. We cannot exclude the possibility that WTAP may have additional roles requisite in many, if not all, cell types. A recent report demonstrated that the WT-1 (ϩKTS) isoform is involved in translational enhancement of an unspliced RNA with a retained intron (25) . Further studies are needed to clarify the role of WTAP in cellcycle regulation and should yield novel insights into the posttranscriptional mechanisms involved in cell-cycle regulation.
Materials and Methods
Cell Culture. HUVEC (Clonetics, La Jolla, CA) were cultured in EGM2 medium (Clonetics). HUVEC were used within the first six passages. For synchronization studies, HUVEC were serumstarved in EBM2 (Clonetics) for 36 h, then released by exchange medium to EGM2. Normal human dermal fibroblasts (Clonetics) were cultured in FGM-2 medium (Clonetics).
RNAi. For WTAP RNAi analysis, siRNA duplexes targeting the sequences AAG CTT TGG AGG GCA AGT ACA (Qiagen, Valencia, CA) or Qiagen control siRNA were transfected with lipofectamine 2000 (Invitrogen, Carlsbad, CA), according to the manufacturer's protocol. Growth medium was replaced 6 h after transfection.
Generation of the WTAP-Knockout Mice. WTAP-knockout mice were obtained from Lexicon Genetics (The Woodlands, TX). Genomic DNA was extracted from mouse tail or embryo yolk sac by using a DNeasy kit (Qiagen). Genotyping was done by PCR by using the following primers to simultaneously amplify both WT (341 bp) and mutated (mut, 255 bp) alleles; A, 5Ј-AAATGCGGTCT GGAGAGAGA-3Ј; B, 5Ј-CCTAACTTGCCCCAGCAGTA-3Ј; LTR, 5Ј-AAATGGCGTTACTTAAGCTAGCTTGC-3Ј. The original founder mice were 129 SvEvBrd ϫ C57BL͞6 heterozygotes from the F 2 generation. Heterozygous mice were maintained by backcross with C57BL͞6 mice until the N 7 generation. Similar results were observed in mice from earlier generations and the N 7 generation.
Statistics. All experiments were performed a minimum of three times. Data points represent the mean Ϯ SD calculated from multiple independent experiments. Statistically significant differences for data points and half-life curves represent P Ͻ 0.05 and were calculated by using either the unpaired t test or analysis of variance [Fisher's Least Significant Difference (LSD) test]. Statis- tical analyses were performed by using Statview version 5 software (Abacus Concepts, Berkeley, CA).
